Who
Richard Chen
President and CMO
Company insider
Files Form 4 as: President and CMO, Personalis.
In numbers
- Trades disclosed
- 126
- Buys
- 0
- Sells
- 57
- Bought
- $0
- Sold
- $10.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Mar 2012
- Last trade
- 18 Sep 2026
- Last filed
- 22 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 22 Sep 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $65K3,998 at $16.22 | filing |
| 18 Sep 2026filed 22 Sep 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $65K3,998 at $16.22 | filing |
| 15 Jul 2026filed 15 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $244K100,000 at $2.44 | filing |
| 15 Jul 2026filed 15 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1.5M100,000 at $15.15 | filing |
| 15 Jul 2026filed 15 Jul 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 15 Jul 2026filed 15 Jul 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 15 Jul 2026filed 15 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code M | $244K100,000 at $2.44 | filing |
| 15 Jul 2026filed 15 Jul 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $1.5M100,000 at $15.15 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —46,875 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —281,250 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —281,250 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Code A | —46,875 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 28 Jul 2025filed 30 Jul 2025 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $2,970452 at $6.57 | filing |
| 16 May 2025filed 20 May 2025 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $4,505910 at $4.95 | filing |
| 15 Mar 2025filed 18 Mar 2025 | PSNL Personalisoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 28 Jan 2025filed 30 Jan 2025 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $3,005519 at $5.79 | filing |
| 16 Dec 2024filed 18 Dec 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $18K4,834 at $3.82 | filing |
| 18 Nov 2024filed 20 Nov 2024 | PSNL PersonalisDiagnostics & Labs | SEC FORM 4 Sold | $3,491921 at $3.79 | filing |
News
Personalis, Inc.: Personalis NeXT Personal Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026PSNL · finanznachrichten.de · 21 Oct 2026
0 headlines in the last 90 days name Richard Chen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.